News
News-Medical.Net on MSN
Advancing drug discovery with AI, generative chemistry, and 3D molecular design
Matthew Segall CEO Optibrium Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO ...
Reasoning models are not uncommon in the world of AI. Many companies have them, including OpenAI's GPT-o3 and Google's Gemini 2.5. But AI image and video company Luma AI just dropped its first AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results